Molecular cloning of c-met 6.0 Kb abnormal transcript
c-met 6.0 Kb异常转录本的分子克隆
基本信息
- 批准号:05670175
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The expression of 6.0 Kb c-met abnormal transcript was proven to be closely correlated with progression and metastasis of gastric cancer. The aim of this grant aided research termed between 1993 and 1995 was to clone this c-met abnormal transcript and clarify the nature of c-met transcripts in neoplastic and non-neoplastic gastric tissue. The results and estimations of the research are summarized as following :1. The attempt for the molecular cloning of 6.0 Kb c-metabnormal transcript was conducted with (1) cDNA library from gastric cancer cell line KATO-III, (2) high molecular weight pAP3 neo cDNA library from MKN-28 stomach cancer cell line and (3) genomic DNA library from normal human peripheral white blood cell using pmetH probe. Although several positive clones were obtained from each library system, the full length 6.0 Kb abnormal transcript could not be available. The cause of the cloning failure was considered to be due to the large size as well as the rarity of the target transcript. Some highly sensitive like lonk RT-PCR cloning may improve the cloning efficiency.2. Fragments of c-met cDNA were analyzed by RT-PCR method. Gastric cancer tissue as well as corresponding normal gastric mucosa was found to express a splice variant lacking nt 2265 to nt 2319 of c-metcDNA preferentially (Yokozaki, H., et al., Oncology Reports, 3,1996 (in press) ).3. Loss of heterozygosity (LOH) on the long arm of the chromosome 7 including c-met locus in human gastric carcinoma tissues was analyzed extensively. Cases with LOH at D7S95 showed significantly worse prognosis than those without the LOH.This finding suggested that D7S95 locus on 7q may contain a candidate suppressor gene for the progression of gastric carcinoma.
6.0Kb c-met异常转录本的表达与胃癌的进展和转移密切相关。这项在1993年至1995年期间资助的研究的目的是克隆这种c-met异常转录本,并阐明肿瘤性和非肿瘤性胃组织中c-met转录本的性质。本研究的主要结果与估计如下:1.用pmetH探针分别从人胃癌细胞株KATO-Ⅲ、人胃癌细胞株MKN-28和正常人外周血白色细胞基因组DNA文库中克隆了6.0Kb的c-metabormal转录本。虽然从每个文库系统中获得了几个阳性克隆,但不能获得全长6.0Kb的异常转录本。克隆失败的原因被认为是由于目标转录本的大尺寸以及稀有性。一些高灵敏度的克隆如lonk RT-PCR克隆可提高克隆效率.用RT-PCR方法分析c-met cDNA片段。发现胃癌组织以及相应的正常胃粘膜优先表达缺乏c-metcDNA的nt 2265至nt 2319的剪接变体(Yokozaki,H.,例如,肿瘤学报告,1996年3月(印刷中))。3.本研究对胃癌组织中包括c-met基因在内的7号染色体长臂上的杂合性缺失(洛)进行了广泛的分析。D 7 S95位点洛缺失者的预后明显差于无洛缺失者,提示D 7 S95位点可能是胃癌发生发展的一个候选抑制基因。
项目成果
期刊论文数量(70)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tannapfel A: "Effect of hepatocyte growth factor on the expression of E-and P-cadherin in gastric carcinoma cell lines" Virchows Archiv. 425. 139-144 (1994)
Tannapfel A:“肝细胞生长因子对胃癌细胞系中 E-和 P-钙粘蛋白表达的影响”Virchows Archive。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tahara, H.: "Telomerase activity in preneoplastic and neoplastic gastric and colorectall lesions" Clinical Cancer Research. 1. 1245-1251 (1995)
Tahara, H.:“胃癌前和肿瘤性胃和结直肠病变中的端粒酶活性”临床癌症研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yokozaki,H.: "Biologic effect of human hepatocyte growth factor on human gastric carcinoma cell lines" Int.J.Oncol.3. 89-93 (1993)
Yokozaki,H.:“人肝细胞生长因子对人胃癌细胞系的生物学效应”Int.J.Oncol.3。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kuniyasu, H.: "A berrant expression of c-met mRNA in human gastric carcinomas" International Journal of Cancer. 55. 72-75 (1993)
Kuniyasu, H.:“c-met mRNA 在人类胃癌中的异常表达”国际癌症杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ayhan, A.: "Loss of heterozygosity at the bcl-2 gene locus and expression of bct-2 gene in gastric and colorectal carcinomas" Japanese Journal of Cancer Research. 85. 584-591 (1994)
Ayhan, A.:“bcl-2 基因位点杂合性丢失以及 bct-2 基因在胃癌和结直肠癌中的表达”日本癌症研究杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOKOZAKI Hiroshi其他文献
YOKOZAKI Hiroshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOKOZAKI Hiroshi', 18)}}的其他基金
Analysis of M2 macrophage/cancer interaction in carcinogenesis, growth and progression of human esophageal squamous cell carcinoma
M2巨噬细胞/癌症相互作用在人食管鳞状细胞癌发生、生长和进展中的分析
- 批准号:
23590397 - 财政年份:2011
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of function of Cdx2 in gastric mucosal stem cells
Cdx2在胃粘膜干细胞中的功能分析
- 批准号:
20590341 - 财政年份:2008
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
INVOLVEMENT OF THE INACTIVATION OF DNA MISMATCH REPAIR SYSTEM ON THE CELLULAR IMMORTALIZATION MECHANISMS OF HUMAN GASTROINTESTINAL CANCERS.
DNA 错配修复系统失活对人类胃肠癌细胞永生化机制的影响。
- 批准号:
14370070 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of inactivation mechanism for mismatch repair system in gastric carcinomas with micro satellite instability
微卫星不稳定性胃癌错配修复系统失活机制分析
- 批准号:
12670163 - 财政年份:2000
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of cyclin E as an oncogene for human gastrointestinal tract cancer
细胞周期蛋白 E 作为人类胃肠道癌癌基因的作用
- 批准号:
09670186 - 财政年份:1997
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
大豆MYB(v-myb avian myeloblastosis viral oncogene homolog)转录因子基因对大豆异黄酮合成调控的研究
- 批准号:31371641
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
相似海外基金
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
- 批准号:
10090714 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Collaborative R&D
Targeting MCPyV oncogene transcription to suppress tumorigenesis
靶向 MCPyV 癌基因转录抑制肿瘤发生
- 批准号:
10753259 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Driver Oncogene変異と子宮頸がんの標的療法の開発
驱动癌基因突变与宫颈癌靶向治疗的发展
- 批准号:
23K08854 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
癌基因激活线粒体未折叠蛋白反应调节衰老生物学
- 批准号:
10598922 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Investigation of the oncogenic mechanism of novel oncogene SETDB1 in gastrointestinal cancer
新癌基因SETDB1在胃肠道癌中的致癌机制研究
- 批准号:
23K08116 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathways of oncogene-induced senescence at DNA replication forks
癌基因诱导 DNA 复制叉衰老的途径
- 批准号:
10603686 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic Leukemia
磷酸酶 PRL3 作为急性淋巴细胞白血病的 MYC 靶点和促生存癌基因
- 批准号:
10527104 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
靶向微环境/癌基因合作治疗预后不良的 T-ALL
- 批准号:
10659661 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Immune control of oncogene selection in preneoplastic colon
癌前结肠癌基因选择的免疫控制
- 批准号:
10740144 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Targeting AVIL, a novel oncogene in rhabdomyosarcoma
针对横纹肌肉瘤中的一种新型癌基因 AVIL
- 批准号:
10585061 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:














{{item.name}}会员




